Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effect of Microneedling With Low Energy Laser in Androgenic Alopecia Patients.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03723369
Recruitment Status : Recruiting
First Posted : October 29, 2018
Last Update Posted : April 30, 2019
Sponsor:
Information provided by (Responsible Party):
Shin Kong Wu Ho-Su Memorial Hospital

Brief Summary:

Androgenetic alopecia is the most common type of hair loss in men, and affects approximately 50 percent of Caucasian men by age 50. The condition is characterized by the progressive loss of terminal hairs on the scalp in a characteristic distribution. The anterior scalp, mid scalp, temporal scalp, and vertex of the scalp are typical sites of involvement. "Male balding" and "male pattern hair loss" are additional terms used to refer to this condition.

The aim of this study is to investigate the effect of microneedling in androgenic alopecia


Condition or disease Intervention/treatment Phase
Dermatologic Disease Device: accupuncture Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 30 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: The Effect of Microneedling With Low Energy Laser in Androgenic Alopecia Patients.
Actual Study Start Date : October 30, 2018
Estimated Primary Completion Date : October 30, 2019
Estimated Study Completion Date : December 30, 2020

Resource links provided by the National Library of Medicine



Intervention Details:
  • Device: accupuncture
    accupuncture


Primary Outcome Measures :
  1. hair regrowth(7-point rating scale (-3 = greatly decreased, -2 = moderately decreased, -1 = slightly decreased, 0 = no change, +1 = slightly increased, +2 = moderately increased, +3 = greatly increased).) [ Time Frame: 12weeks ]
    hair regrowth(7-point rating scale (-3 = greatly decreased, -2 = moderately decreased, -1 = slightly decreased, 0 = no change, +1 = slightly increased, +2 = moderately increased, +3 = greatly increased).)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   20 Years to 60 Years   (Adult)
Sexes Eligible for Study:   Male
Gender Based Eligibility:   Yes
Gender Eligibility Description:   androgenic alopecia
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

- androgenic alopecia patients

Exclusion Criteria:

  • infection, immune disorder, other dermatosis in treating areas

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03723369


Contacts
Layout table for location contacts
Contact: Gong Yau Chu, MD 886 987057172 aguest122@hotmail.com.tw

Locations
Layout table for location information
Taiwan
ShinKongHospital Recruiting
Taipei, Taiwan
Contact: Gong Yau Chu, MD         
Sponsors and Collaborators
Shin Kong Wu Ho-Su Memorial Hospital

Layout table for additonal information
Responsible Party: Shin Kong Wu Ho-Su Memorial Hospital
ClinicalTrials.gov Identifier: NCT03723369     History of Changes
Other Study ID Numbers: 20180301R
First Posted: October 29, 2018    Key Record Dates
Last Update Posted: April 30, 2019
Last Verified: October 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Alopecia
Skin Diseases
Hypotrichosis
Hair Diseases
Pathological Conditions, Anatomical